Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0699+0.0099 (+0.93%)
At close: 11:43AM EDT
1.0900 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.74M
Enterprise value 9.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.09
Price/book (mrq)1.95
Enterprise value/revenue 0.92
Enterprise value/EBITDA -2.28

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-75.68%
S&P500 52-week change 3-10.33%
52-week high 34.8300
52-week low 30.9100
50-day moving average 31.1528
200-day moving average 31.2320

Share statistics

Avg vol (3-month) 316.85k
Avg vol (10-day) 36.76k
Shares outstanding 510.46M
Implied shares outstanding 6N/A
Float 85.65M
% held by insiders 110.01%
% held by institutions 140.78%
Shares short (14 Mar 2023) 420.3k
Short ratio (14 Mar 2023) 40.92
Short % of float (14 Mar 2023) 40.32%
Short % of shares outstanding (14 Mar 2023) 40.20%
Shares short (prior month 14 Feb 2023) 422.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 309 July 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 309 July 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin -74.00%
Operating margin (ttm)-43.46%

Management effectiveness

Return on assets (ttm)-18.91%
Return on equity (ttm)-36.20%

Income statement

Revenue (ttm)9.97M
Revenue per share (ttm)0.97
Quarterly revenue growth (yoy)-5.70%
Gross profit (ttm)4.73M
EBITDA -3.98M
Net income avi to common (ttm)-4.55M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.63M
Total cash per share (mrq)0.35
Total debt (mrq)1.09M
Total debt/equity (mrq)12.31
Current ratio (mrq)5.85
Book value per share (mrq)0.54

Cash flow statement

Operating cash flow (ttm)-3.23M
Levered free cash flow (ttm)-295.88k